4.6 Review

Ginger: Panacea or Consumer's Hype?

Journal

APPLIED SCIENCES-BASEL
Volume 9, Issue 8, Pages -

Publisher

MDPI
DOI: 10.3390/app9081570

Keywords

bioavailability; medication interactions; clinical trials; encapsulation; nano-carriers

Funding

  1. Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) [PEst C-QUI/UI0062/2019]
  2. European Union
  3. QREN
  4. European Fund for Regional Development (FEDER), through the programme COMPETE

Ask authors/readers for more resources

Ginger in its many forms, from juices of the fresh rhizome, to ginger powder and ginger essential oil, is growing in popularity for claimed universal health benefits. Nevertheless, and contrarily to the common notion of the public, ginger is not devoid of side effects, especially interactions with other drugs, and many of the claimed benefits remain to be substantiated. This work presents a comprehensive revision of the current state of the art on ginger pharmacokinetics and bioavailability, interaction with active pharmaceutical ingredients, raising awareness of the risks of uncontrolled ginger consumption. A second section of the work described the verified actions of various extracts of ginger, or of their main active ingredients, gingerols, based mainly on data obtained from controlled clinical trials. Finally, the last section is devoted to innovative technological solutions to improve the bioavailability of gingerols and ginger extracts that are expected to ultimately lead to the development of more consumer-compliant products.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available